HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O V Kalyuzhin Selected Research

glucosaminylmuramyl- 2- alanine- D- isoglutamine

1/2021[BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic].
12/2020[BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O V Kalyuzhin Research Topics

Disease

4Respiratory Tract Infections (Respiratory Tract Infection)
01/2021 - 01/2016
3Periodontitis
01/2022 - 01/2020
3Infections
12/2020 - 05/2008
2Periodontal Pocket (Periodontal Pockets)
01/2022 - 01/2021
2COVID-19
01/2021 - 12/2020
2Periodontal Diseases (Periodontal Disease)
01/2021 - 01/2020
2Sepsis (Septicemia)
05/2008 - 05/2003
1Dental Deposits
01/2022
1Pneumonia (Pneumonitis)
10/2021
1Virus Diseases (Viral Diseases)
10/2021
1Human Influenza (Influenza)
10/2021
1Experimental Melanoma
04/2021
1Neoplasms (Cancer)
04/2021
1Chronic Periodontitis
01/2021
1Embryo Loss
04/2020
1Fever (Fevers)
11/2018
1Chronic Hepatitis C
01/2017
1Chronic Hepatitis B
01/2017
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2017
1Spontaneous Abortion (Miscarriage)
05/2015
1Inflammation (Inflammations)
01/2015
1Body Weight (Weight, Body)
03/2006
1Glomerulonephritis
12/2004
1Opisthorchiasis
12/2004
1Bacterial Infections (Bacterial Infection)
05/2003

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
01/2022 - 05/2003
5Acetylmuramyl-Alanyl-IsoglutamineIBA
04/2020 - 05/2003
4CytokinesIBA
10/2021 - 12/2004
3InterferonsIBA
10/2021 - 01/2017
3GlycosidesIBA
10/2009 - 05/2003
2glucosaminylmuramyl- 2- alanine- D- isoglutamineIBA
01/2021 - 12/2020
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2021 - 04/2020
1DefensinsIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1EnzymesIBA
01/2022
1Tilorone (Tilorone Hydrochloride)IBA
10/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2021
1Bacterial LysatesIBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1Peptidoglycan (Murein)IBA
12/2020
1VaccinesIBA
12/2020
1BCG VaccineFDA Link
12/2020
1AntigensIBA
04/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1Anti-Infective Agents (Microbicides)IBA
01/2020
1Dosage Forms (Dosage Form)IBA
11/2018
1Antiviral Agents (Antivirals)IBA
11/2018
1AntioxidantsIBA
11/2018
1VitaminsIBA
01/2016
1SmokeIBA
01/2015
1Triglycerides (Triacylglycerol)IBA
03/2006
1Perilipin-1IBA
03/2006
1Sterol Esterase (Hormone-Sensitive Lipase)IBA
03/2006
1Antigen-Antibody Complex (Immune Complex)IBA
12/2004

Therapy/Procedure

1Oral Hygiene (Dental Hygiene)
01/2022
1Aftercare (After-Treatment)
01/2021
1Therapeutics
11/2018
1Intraperitoneal Injections
05/2003